Single-center experience with cyclosporine therapy for kidney transplantation: Analysis of a twenty-year period in 1200 patients

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S83-S88

  Snanoudj, R ^a   Kriaa, F ^a   Arzouk, N ^a   Beaudreuil, S ^a   Hiesse, C ^a   Durrbach, A ^a   Charpentier, B ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CREATININE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; INSULIN; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BASAL CELL CARCINOMA; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTITIS; DEATH; DIABETES MELLITUS; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPOSI SARCOMA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; PROSTATITIS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREMOR; TUBERCULOSIS; URINARY TRACT INFECTION;

EID: 1642308762     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.089     Document Type: Article

References (9)

1. The Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. N Engl J Med. 314:1986;1219.
2. Ponticelli C., Minetti L., Di Palo F.Q., et al. The Milan clinical trial with cyclosporine in cadaveric renal transplantation. A three-year follow-up. Transplantation. 45:1988;908.
3. Mueller E.A., Kovarik J.M., van Bree J.B., et al. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients-a concentration-controlled comparison with the commercial formulation. Transplantation. 57:1994;1178.
4. Isoniemi H.M., Ahonen J., Tikkanen M.J., et al. Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation. 55:1993;494.
5. Nankivell B.J., Hibbins M., Chapman J.R. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy. Transplantation. 58:1994;989.
6. United Network Organ Sharing 1996 Annual report. Richmond, VA, 1996.
7. Francois H., Durrbach A., Amor M., et al. The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management. Nephrol Dial Transplant. 18:2003;1909.
8. Opelz G., Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 342:1993;1514.
9. Hiesse C., Kriaa F., Rieu P., et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine- treated recipients analysis of a 20-year period in 1600 patients. Transplant Proc. 27:1995;972.